These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7596256)

  • 1. [Epidemiologic studies and treatment of chronic viral hepatitis C].
    Ouzan D
    Med Trop (Mars); 1994; 54(3 Suppl):18-20. PubMed ID: 7596256
    [No Abstract]   [Full Text] [Related]  

  • 2. [How many patients with chronic viral hepatitis qualify for interferon therapy? Prospective analysis of university ambulatory care].
    Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
    Med Klin (Munich); 1993 Sep; 88(9):511-5, 562. PubMed ID: 8232088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic hepatitis C: a growing problem].
    Mihm S; Ramadori G
    Leber Magen Darm; 1995 Mar; 25(2):68-70. PubMed ID: 7752800
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapy in chronic hepatitis C: say goodbye to the 6-month interferon regimen.
    Koff RS
    Am J Gastroenterol; 1996 Oct; 91(10):2072-4. PubMed ID: 8855723
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mucocutaneous lichen planus induced by a second treatment with high-dose interferon-alpha in a patient with chronic viral hepatitis C].
    Perreard M; Constant T; Monges D; Djaghri N; Angeli-Besson C; Gerolami A
    Gastroenterol Clin Biol; 1994; 18(11):1051. PubMed ID: 7705576
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of chronic hepatitis B, C and D with alpha-interferon].
    Niederau C
    Fortschr Med; 1993 Feb; 111(6):35-7. PubMed ID: 8462911
    [No Abstract]   [Full Text] [Related]  

  • 7. [Predictive factors of response to interferon-alpha treatment in chronic hepatitis C].
    Buti M; Esteban R
    Rev Esp Enferm Dig; 1997 Jul; 89(7):501-2. PubMed ID: 9303619
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy of acute and chronic viral hepatitis C (non-A, non-B) with interferon-alpha].
    Alscher DM; Bode JC
    Med Klin (Munich); 1992 Oct; 87(10):532-9. PubMed ID: 1461219
    [No Abstract]   [Full Text] [Related]  

  • 9. [Epidemiology and clinical aspects of chronic viral hepatitis].
    Heintges T; Niederau C; Niederau M; Stremmel W
    Z Gastroenterol; 1993 Nov; 31 Suppl 5():42-5. PubMed ID: 8197800
    [No Abstract]   [Full Text] [Related]  

  • 10. Interferon therapy in hepatitis C--refractory hepatitis--report of the research subgroup of treatment of chronic hepatitis.
    Iino S
    Gastroenterol Jpn; 1993 Mar; 28 Suppl 4():139-42. PubMed ID: 8486225
    [No Abstract]   [Full Text] [Related]  

  • 11. The treatment of chronic viral hepatitis.
    Hoofnagle JH; di Bisceglie AM
    N Engl J Med; 1997 Jan; 336(5):347-56. PubMed ID: 9011789
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of chronic viral hepatitis].
    Marcellin P; Metreau JM; Pol S; Zoulim F
    Ann Gastroenterol Hepatol (Paris); 1996; 32(2):85-7. PubMed ID: 8737503
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chronic hepatitis: the etiological spectrum. The implications for treatment].
    Velosa J; Ramalho F; Serejo F; Marinho R; de Moura MC
    Acta Med Port; 1993 Jun; 6(6):233-8. PubMed ID: 8368089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Factors of response to treatment with interferon-alpha in patients with chronic hepatitis C. Therapeutic perspectives].
    Marcellin P; Pouteau M; Martinot M; Boyer N; Castelnau C; Benhamou JP; Erlinger S
    Gastroenterol Clin Biol; 1995 Dec; 19(12):991-1000. PubMed ID: 8729410
    [No Abstract]   [Full Text] [Related]  

  • 15. alpha-Interferon therapy for hepatitis C virus chronic infection with mixed cryoglobulinemia.
    Castilla A; Castilla I; Prieto J
    Am J Gastroenterol; 1993 Mar; 88(3):466-7. PubMed ID: 8438868
    [No Abstract]   [Full Text] [Related]  

  • 16. Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapy.
    Mels GC; Roffi L; Antonelli G; Bellati G; Pacchetti S; Di Nolfo MA; Panizzuti F; Moretti G; Piperno A; Pozzi M
    Prog Clin Biol Res; 1993; 382():359-64. PubMed ID: 8502704
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost effectiveness of interferon in chronic active hepatitis C.
    Sallie R
    Med J Aust; 1994 Jul; 161(2):169-70. PubMed ID: 8080533
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chronic hepatitis. Differential diagnosis and therapy. 2: Differential hepatitis C diagnosis].
    Schlaak JF; Gerken G
    Fortschr Med; 1997 Jul; 115(20-21):38-9. PubMed ID: 9333584
    [No Abstract]   [Full Text] [Related]  

  • 19. Response of chronic hepatitis C to interferon-alpha treatment and relationship with iron metabolism.
    Martín-Vivaldi R; Nogueras F; González A; Quintero D; Pinel LM; Castro T; Hernández A
    Rev Esp Enferm Dig; 1997 Jul; 89(7):523-30. PubMed ID: 9265838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness of interferon in chronic active hepatitis C.
    Turnbull C; Sugano D
    Med J Aust; 1994 Jul; 161(2):169; author reply 170. PubMed ID: 8028544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.